These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 28977808)

  • 61. A highly stable Yarrowia lipolytica lipase formulation for the treatment of pancreatic exocrine insufficiency.
    Turki S; Mrabet G; Jabloun Z; Destain J; Thonart P; Kallel H
    Biotechnol Appl Biochem; 2010 Dec; 57(4):139-49. PubMed ID: 20958263
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency.
    Stern RC; Eisenberg JD; Wagener JS; Ahrens R; Rock M; doPico G; Orenstein DM
    Am J Gastroenterol; 2000 Aug; 95(8):1932-8. PubMed ID: 10950038
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Should we Investigate Gastroenterology Patients for Pancreatic Exocrine Insufficiency? A Dual Centre UK Study.
    Campbell JA; Sanders DS; Francis KA; Kurien M; Lee S; Taha H; Ramadas A; Joy D; Hopper AD
    J Gastrointestin Liver Dis; 2016 Sep; 25(3):303-9. PubMed ID: 27689193
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [The clinical application of 13C-breath tests in pancreatic diseases].
    Cherniavskiĭ VV
    Lik Sprava; 2014 Nov; (11):76-82. PubMed ID: 25528838
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Preliminary report of the (13)C-mixed triglyceride breath test to assess timing of pancreatic enzyme replacement therapy in children with cystic fibrosis.
    van der Haak N; Boase J; Davidson G; Butler R; Miller M; Kaambwa B; Kritas S
    J Cyst Fibros; 2016 Sep; 15(5):669-74. PubMed ID: 27102891
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pancreatic Insufficiency and an Absent Gallbladder: Connecting the Dots.
    Bronswijk M; Gillard P; van Malenstein H
    Gastroenterology; 2020 Aug; 159(2):e8-e9. PubMed ID: 32017909
    [No Abstract]   [Full Text] [Related]  

  • 67. Pertzye approved for pancreatic insufficiency.
    Traynor K
    Am J Health Syst Pharm; 2012 Jul; 69(13):1094. PubMed ID: 22722581
    [No Abstract]   [Full Text] [Related]  

  • 68. Somatostatin analogue-induced pancreatic exocrine insufficiency in patients with neuroendocrine tumors: results of a prospective observational study.
    Lamarca A; McCallum L; Nuttall C; Barriuso J; Backen A; Frizziero M; Leon R; Mansoor W; McNamara MG; Hubner RA; Valle JW
    Expert Rev Gastroenterol Hepatol; 2018 Jul; 12(7):723-731. PubMed ID: 29923433
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pancreatic enzyme replacement therapy dosing and nutritional outcomes in children with cystic fibrosis.
    Haupt ME; Kwasny MJ; Schechter MS; McColley SA
    J Pediatr; 2014 May; 164(5):1110-1115.e1. PubMed ID: 24560182
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pancreatic enzyme supplementation.
    Wier HA; Kuhn RJ
    Curr Opin Pediatr; 2011 Oct; 23(5):541-4. PubMed ID: 21799412
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical, anthropometric and laboratory nutritional markers of pancreatic exocrine insufficiency: Prevalence and diagnostic use.
    Lindkvist B; Phillips ME; Domínguez-Muñoz JE
    Pancreatology; 2015; 15(6):589-97. PubMed ID: 26243045
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pancreatic exocrine insufficiency in pancreatic cancer: A review of the literature.
    Bartel MJ; Asbun H; Stauffer J; Raimondo M
    Dig Liver Dis; 2015 Dec; 47(12):1013-20. PubMed ID: 26211872
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Enzyme replacement improves survival among patients with pancreatic cancer: Results of a population based study.
    Roberts KJ; Bannister CA; Schrem H
    Pancreatology; 2019 Jan; 19(1):114-121. PubMed ID: 30385188
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pancreatic Exocrine Insufficiency after Bariatric Surgery.
    Vujasinovic M; Valente R; Thorell A; Rutkowski W; Haas SL; Arnelo U; Martin L; Löhr JM
    Nutrients; 2017 Nov; 9(11):. PubMed ID: 29137169
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pancreatic Enzyme Replacement Therapy for Patients Diagnosed With Pancreaticobiliary Cancer: Validation of an Algorithm for Dose Escalation and Management.
    Carnie LE; Farrell K; Barratt N; Abraham M; Gillespie L; Satyadas T; McNamara MG; Hubner RA; Geraghty J; Bibby N; Valle JW; Lamarca A
    Pancreas; 2021 Oct; 50(9):1254-1259. PubMed ID: 34860808
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Omeprazole as adjunct to enzyme replacement in severe pancreatic insufficiency.
    Lamers CB; Jansen JB
    Br Med J (Clin Res Ed); 1986 Oct; 293(6553):994. PubMed ID: 3094768
    [No Abstract]   [Full Text] [Related]  

  • 77. Efficacy and tolerability of Creon for Children in infants and toddlers with pancreatic exocrine insufficiency caused by cystic fibrosis: an open-label, single-arm, multicenter study.
    Colombo C; Fredella C; Russo MC; Faelli N; Motta V; Valmarana L; Longo L; D'Orazio C
    Pancreas; 2009 Aug; 38(6):693-9. PubMed ID: 19531972
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Medical nutrition therapy for cystic fibrosis: beyond pancreatic enzyme replacement therapy.
    Hayek KM
    J Am Diet Assoc; 2006 Aug; 106(8):1186-8. PubMed ID: 16863713
    [No Abstract]   [Full Text] [Related]  

  • 79. Fecal Elastase Fails to Detect Steatorrhea in Patients With Locally Advanced Pancreatic Cancer.
    Witvliet-van Nierop JE; Wierdsma NJ; Ottens-Oussoren K; Meijerink MR; Bouma G; Kazemier G; de van der Schueren MAE
    Pancreas; 2018 Apr; 47(4):e15-e16. PubMed ID: 29521945
    [No Abstract]   [Full Text] [Related]  

  • 80. Change in enzyme content and manufacturer of Viokase.
    Berardi RR; Colvin CL
    Clin Pharm; 1985; 4(4):388. PubMed ID: 4042558
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.